[Interferons alpha in the treatment of chronic HCV infections]

Abstract

Interferons play the main role in the treatment of chronic hepatitis C. In the clinical practice recombined forms of these cytokines dominate. Most recent obligatory standard of the treatment is combined therapy with pegylated interferon and ribavirin during 24 or 48 weeks dependent of HCV genotype. In some clinical cases, in which contraindications to these forms of drugs or adverse events appear, administration of natural interferon (alphaferon) is possible. Treatment with this form of interferon in these cases is safe and efficient.